References
- Yeh JJ, Hsu NY, Hsu WH, et al (2005). Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer. Lung, 183, 177-83. https://doi.org/10.1007/s00408-004-2532-1
- Bawa-Khalfe T, Yeh ET (2010). SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression. Genes Cancer, 1, 748-52. https://doi.org/10.1177/1947601910382555
- Cavard, C, S Colnot, V Audard, et al (2008). Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. Future Oncol, 4, 647-60. https://doi.org/10.2217/14796694.4.5.647
- Cheng J, Bawa T, Lee P, et al (2006). Role of desumoylation in the development of prostate cancer. Neoplasia, 8, 667-76. https://doi.org/10.1593/neo.06445
- Cheng J, Kang X, Zhang S, et al (2007). SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell, 131, 584-95. https://doi.org/10.1016/j.cell.2007.08.045
- Chiu SY, Asai N, Costantini F, et al (2008). SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages. PLoS Biol, 6, e310. https://doi.org/10.1371/journal.pbio.0060310
- David R (2010). Sumoylation: Targeting SUMO. Nat Rev Mol Cell Biol, 11, 387.
- Di Bacco A, Gill G (2006). SUMO-specific proteases and the cell cycle. An essential role for SENP5 in cell proliferation. Cell Cycle, 5, 2310-3. https://doi.org/10.4161/cc.5.20.3367
- Geiss-Friedlander R, Melchior F (2007). Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol, 8, 947-56. https://doi.org/10.1038/nrm2293
- Haindl M, Harasim T, Eick T, et al (2008). The nucleolar SUMOspecific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing. EMBO Rep, 9, 273-9. https://doi.org/10.1038/embor.2008.3
- Hang J, Dasso M (2002). Association of the human SUMO-1 protease SENP2 with the nuclear pore. J Biol Chem, 277, 19961-6. https://doi.org/10.1074/jbc.M201799200
- Huang H, He X (2008). Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol, 20, 119-25. https://doi.org/10.1016/j.ceb.2008.01.009
- Itahana Y, Yeh ET, Zhang Y (2006). Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2. Mol Cell Biol, 26, 4675-89. https://doi.org/10.1128/MCB.01830-05
- Kang X, Qi Y, Zuo Y, et al (2010). SUMO-specific protease 2 is essential for suppression of polycomb group proteinmediated gene silencing during embryonic development. Mol Cell, 38, 191-201. https://doi.org/10.1016/j.molcel.2010.03.005
- Lam AP, Gottardi CJ (2011). Beta-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol, 23, 562-7. https://doi.org/10.1097/BOR.0b013e32834b3309
- Li SJ, Hochstrasser M (1999). A new protease required for cellcycle progression in yeast. Nature, 398, 246-51. https://doi.org/10.1038/18457
- MacDonald BT, Tamai K, He X (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell, 17, 9-26. https://doi.org/10.1016/j.devcel.2009.06.016
- Vertegaal AC (2010). SUMO chains: polymeric signals. Biochem Soc Trans, 38, 46-49. https://doi.org/10.1042/BST0380046
- Wang Y, Dasso M (2009). SUMOylation and deSUMOylation at a glance. J Cell Sci, 122, 4249-52. https://doi.org/10.1242/jcs.050542
- White BD, Chien AJ, Dawson DW (2012). Dysregulation of Wnt/beta-catenin signaling in gastrointestinal cancers. Gastroenterology, 142, 219-32. https://doi.org/10.1053/j.gastro.2011.12.001
- Woo CH, Abe J (2010). SUMO--a post-translational modification with therapeutic potential? Curr Opin Pharmacol, 10, 146-55. https://doi.org/10.1016/j.coph.2009.12.001
- Zhang XF, Tan X, Zeng G, et al (2010). Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling. Hepatology, 52, 954-65.
Cited by
- Aberrant sumoylation signaling evoked by reactive oxygen species impairs protective function of Prdx6 by destabilization and repression of its transcription vol.281, pp.15, 2014, https://doi.org/10.1111/febs.12866
- SENP2 regulated the stability of β-catenin through WWOX in hepatocellular carcinoma cell vol.35, pp.10, 2014, https://doi.org/10.1007/s13277-014-2239-8
- Identification of 1,2,5-Oxadiazoles as a New Class of SENP2 Inhibitors Using Structure Based Virtual Screening vol.54, pp.3, 2014, https://doi.org/10.1021/ci4007134
- Inhibition of SENP5 suppresses cell growth and promotes apoptosis in osteosarcoma cells vol.7, pp.6, 2014, https://doi.org/10.3892/etm.2014.1644
- Functional Proteomics Study Reveals SUMOylation of TFII-I is Involved in Liver Cancer Cell Proliferation vol.14, pp.6, 2015, https://doi.org/10.1021/acs.jproteome.5b00062
- SUMO-specific protease 6 promotes gastric cancer cell growth via deSUMOylation of FoxM1 vol.36, pp.12, 2015, https://doi.org/10.1007/s13277-015-3737-z
- Immortalization of epithelial cells in oral carcinogenesis as revealed by genome-wide array comparative genomic hybridization: A meta-analysis vol.38, pp.S1, 2015, https://doi.org/10.1002/hed.24102
- Protein SUMOylation modification and its associations with disease vol.7, pp.10, 2017, https://doi.org/10.1098/rsob.170167
- SUMO pathway components as possible cancer biomarkers vol.11, pp.11, 2015, https://doi.org/10.2217/fon.15.41